肿瘤细胞减灭术加腹腔热灌注化疗治疗胃癌腹膜癌预后模型的建立与评价

来源 :2019中国肿瘤学大会 | 被引量 : 0次 | 上传用户:jaky111
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的 胃癌腹膜癌预后极差,尚无标准治疗.本研究旨在通过单中心回顾性分析,研究肿瘤细胞减灭术加腹腔热灌注化疗治疗胃癌腹膜癌的有效性,筛选预后预测指标,构建预后预测模型.方法 收集2005 年~2017 年之间于本单位接受肿瘤细胞减灭术加腹腔热灌注化疗综合治疗的115 例胃癌腹膜癌患者临床资料与预后信息,以主要临床病理特征及手术相关指标划分亚组进行统计分析,主要研究终点是总生存期.结果 115 例胃癌腹膜癌患者接受肿瘤细胞减灭术加腹腔热灌注化疗121 次,中位总生存期为13.1月,1 年、2 年、3 年、5 年生存率分别为:56.5%、25.3%、12.6%、8.1%,4 例患者生存时间超过5年.单因素分析显示,性别(P = 0.004)、术前肿瘤标志物(P < 0.001)、腹膜癌时相(P <0.001)、腹腔热灌注化疗温度(P = 0.020)与时长(P = 0.023),肿瘤细胞减灭程度(P <0.001)、严重不良事件(P = 0.085)、辅助化疗类型(P < 0.001)和腹膜癌指数(P < 0.001)亚组总生存期有显著性差异.多因素分析显示,肿瘤细胞减灭程度、腹腔热灌注化疗温度和辅助化疗类型为预测总生存的独立预后因子.结论 肿瘤细胞减灭术加腹腔热灌注化疗综合治疗策略可显著延长胃癌腹膜癌患者总生存期,部分患者可实现临床治愈.完全肿瘤细胞减灭术、43 ℃ 腹腔热灌注化疗和术后系统或系统联合腹腔化疗是胃癌腹膜癌获得最大生存受益的关键.
其他文献
Objective Hepatocellular carcinoma(HCC)is a highly fatal cancer,and it is the second leading cause of cancer death worldwide among men.Despite liver transplantation and surgery are available for early
Objective Neoadjuvant therapy is increasingly used in clinical practice for patients with locally advanced GA.There are few recent studies on survival and recurrence for GA patients following curative
Objective Previous studies have shown that the all-cause mortality and non-colorectal cancer mortality of patients with fecal occult blood test(FOBT)positivity are significantly increased,suggesting t
目的 评价应用术中磁共振(intraoperative Magnetic Resonance Imaging,iMRI)、术中超声(intraoperative ultrasound,iUS)、5-氨酸乙酰丙酸荧光引导技术(fluorescence guided with 5-Aminolevulinic acid,fluorescence guided with 5-ALA)对胶质瘤切除残留的诊
Objective Liver cancer is ranked as the sixth most common neoplasm and the fourth leading cause of cancer death globally.There were 854,000 incident liver cancer cases and 810,000 deaths worldwide in
Objective Retinoblastoma(RB)is the most common intraocular malignancy in childhood,representing 2.5%to 4%of all pediatric cancers,and the annual morbidity is approximately 9,000 new cases develop worl
目的 Skin toxicity,especially hand-foot syndrome(HFS),is the most common sorafenibinduced adverse events in hepatocellular carcinoma(HCC)patients,leading to treatment interruption and failure.Mucocutane
Objective Metastasis-associated protein 1(MTA1)has been reported to be upregulated in multiple malignancies and promotes cancer proliferation and metastasis.However,whether and how MTA1 promotes esoph
Objective Primary breast diffuse large B-cell lymphoma(PB-DLBCL),the most common histologic subtype of lymphoid malignancy in the breast,is a clinically and genetically heterogeneous disease that has
目的 一例同时性乳腺癌和胃癌双原发伴有肝转移患者,根据临床、体检、实验室检查、影像学检查和病理检查结果 ,对该患者肝转移病灶的来源进行鉴别诊断.方法 患者女性,49 岁.主诉:发现右腋下肿块2 月余,发现肝占位1 月.患者2017.8 触及右腋下肿块,质硬,活动性差,右手活动不便.2017.9 触及右锁骨上肿块,约2cm 大小,质硬,无压痛.2017.10.6 外院B 超:右侧乳腺内结节(BI-R